Cargando…

Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s

The situation of secondary hyperparathyroidism (SHPT) in chronic kidney disease patients not on dialysis (ND-CKD) is probably best characterised by the Kidney Disease: Improving Global Outcomes Chronic Kidney Disease–Mineral and Bone Disorder Update 2017 guideline 4.2.1 stating that the optimal para...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ketteler, Markus, Bover, Jordi, Mazzaferro, Sandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229290/ https://www.ncbi.nlm.nih.gov/pubmed/35977397 http://dx.doi.org/10.1093/ndt/gfac236

Ejemplares similares

Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future
por: Brandenburg, Vincent, et al.
Publicado: (2022)

Where are we now? Emerging opportunities and challenges in the management of secondary hyperparathyroidism in patients with non-dialysis chronic kidney disease
por: Ketteler, Markus, et al.
Publicado: (2021)

The Emerging Role of Nutritional Vitamin D in Secondary Hyperparathyroidism in CKD
por: Lu, Chien-Lin, et al.
Publicado: (2018)

Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 study
por: Roggeri, Daniela Paola, et al.
Publicado: (2014)

The Role of Diet in Bone and Mineral Metabolism and Secondary Hyperparathyroidism
por: Bargagli, Matteo, et al.
Publicado: (2021)

Phosphate Metabolism in CKD Stages 3–5: Dietary and Pharmacological Control
por: Ketteler, Markus
Publicado: (2011)

Cinacalcet Treatment of Primary Hyperparathyroidism
por: Rothe, H. M., et al.
Publicado: (2011)

Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism
por: Akizawa, Tadao, et al.
Publicado: (2019)

Positive and Negative Aspects of Sodium Intake in Dialysis and Non-Dialysis CKD Patients
por: Nagasawa, Yasuyuki
Publicado: (2021)

Bone Fragility Fractures in CKD Patients
por: Pimentel, Ana, et al.
Publicado: (2020)

Evocalcet Rescues Secondary Hyperparathyroidism-driven Cortical Porosity in CKD Male Rats
por: Hasegawa, Tomoka, et al.
Publicado: (2023)

Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease
por: Abbas, Fizza, et al.
Publicado: (2019)

Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis
por: Warady, Bradley A., et al.
Publicado: (2020)

Chronic hyperkalemia in non-dialysis CKD: controversial issues in nephrology practice
por: De Nicola, Luca, et al.
Publicado: (2018)

Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism
por: Pérez-Ricart, Ariadna, et al.
Publicado: (2019)

Ectopic ossification in the cranial dura mater in dialysis patients with secondary hyperparathyroidism
por: Oyama, Yuko, et al.
Publicado: (2010)

Current and Emerging Markers and Tools Used in the Diagnosis and Management of Chronic Kidney Disease–Mineral and Bone Disorder in Non-Dialysis Adult Patients
por: Fusaro, Maria, et al.
Publicado: (2023)

Dialysis or a Plant-Based Diet in Advanced CKD in Pregnancy? A Case Report and Critical Appraisal of the Literature
por: Attini, Rossella, et al.
Publicado: (2019)

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide
por: Cozzolino, Mario, et al.
Publicado: (2017)

Roxadustat for CKD-related Anemia in Non-dialysis Patients
por: Coyne, Daniel W., et al.
Publicado: (2020)

Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism
por: Behets, Geert J, et al.
Publicado: (2015)

Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion
por: Giannini, Sandro, et al.
Publicado: (2017)

Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis
por: Pérez-Ricart, Ariadna, et al.
Publicado: (2016)

Risk factors for severe hypocalcemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism
por: Sun, Xiaoliang, et al.
Publicado: (2018)

Evaluation of laboratory parameters and symptoms after parathyroidectomy in dialysis patients with secondary hyperparathyroidism
por: Zhang, Yi, et al.
Publicado: (2019)

The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism
por: Bucharles, Sérgio Gardano Elias, et al.
Publicado: (2019)

Surgical Management of Secondary Hyperparathyroidism
por: Steinl, Gabrielle K., et al.
Publicado: (2020)

Are there sex differences in cardiovascular outcomes in non-dialysis CKD patients?
por: Provenzano, Pasquale Fabio, et al.
Publicado: (2023)

Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial
por: Gaillard, Carlo A., et al.
Publicado: (2016)

New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology
por: Bellasi, Antonio, et al.
Publicado: (2019)

Hyperparathyroidism in a diabetic patient on dialysis
por: Hori, Michiko, et al.
Publicado: (2008)

The Use of Imaging Techniques in Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD)—A Systematic Review
por: Pimentel, Ana, et al.
Publicado: (2021)

Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?
por: Frazão, João M, et al.
Publicado: (2012)

Thyrotoxicosis Occurring in Secondary Hyperparathyroidism Patients Undergoing Dialysis after Total Parathyroidectomy with Autotransplantation
por: Xu, Zhou, et al.
Publicado: (2017)

Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs
por: Roggeri, Alessandro, et al.
Publicado: (2020)

Clinical Significance of Phase Angle in Non-Dialysis CKD Stage 5 and Peritoneal Dialysis Patients
por: Han, Byoung-Geun, et al.
Publicado: (2018)

Reoperation for persistent or recurrent secondary hyperparathyroidism. Surgical treatment of renal hyperparathyroidism
por: Abruzzo, Alida, et al.
Publicado: (2017)

Secondary Hyperparathyroidism and Hypertension: An Intriguing Couple
por: Simeoni, Mariadelina, et al.
Publicado: (2020)

Oral Paricalcitol for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease
por: Cheng, Steven, et al.
Publicado: (2006)

Vitamin D, a modulator of musculoskeletal health in chronic kidney disease
por: Molina, Pablo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_431qckivaooognt1cbjcttu8oo